Abstract

To understand the involvement of matrix metalloproteinases (MMPs) in 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE)-induced angiogenesis, we have studied the role of MMP-2. 15(S)-HETE induced MMP-2 expression and activity in a time-dependent manner in human dermal microvascular endothelial cells (HDMVECs). Inhibition of MMP-2 activity or depletion of its levels attenuated 15(S)-HETE-induced HDMVEC migration, tube formation, and Matrigel plug angiogenesis. 15(S)-HETE also induced Fra-1 and c-Jun expression in a Rac1-MEK1-JNK1-dependent manner. In addition, 15(S)-HETE-induced MMP-2 expression and activity were mediated by Rac1-MEK1-JNK1-dependent activation of AP-1 (Fra-1/c-Jun). Cloning and site-directed mutagenesis of MMP-2 promoter revealed that AP-1 site proximal to the transcriptional start site is required for 15(S)-HETE-induced MMP-2 expression, and Fra-1 and c-Jun are the essential components of AP-1 that bind to MMP-2 promoter in response to 15(S)-HETE. Hind limb ischemia led to an increase in MEK1 and JNK1 activation and Fra-1, c-Jun, and MMP-2 expression resulting in enhanced neovascularization and recovery of blood perfusion in wild-type mice as compared with 12/15-Lox(-/-) mice. Together, these results provide the first direct evidence for a role of 12/15-Lox-12/15(S)-HETE axis in the regulation of ischemia-induced angiogenesis.

Highlights

  • Angiogenesis has been implicated in the pathogenesis of cancer, diabetic retinopathy, and atherosclerosis [1]

  • To understand the involvement of matrix metalloproteinases (MMPs) in 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE)induced angiogenesis, we have studied the role of MMP-2. 15(S)-HETE induced MMP-2 expression and activity in a timedependent manner in human dermal microvascular endothelial cells (HDMVECs)

  • Many studies have focused on the role of 12/15-Lox, a murine ortholog of 15-Lox1, in the pathogenesis of atherosclerosis and restenosis (24 –26, 54), underscoring the importance of 15-Lox/15-HETE in these diseases

Read more

Summary

MATERIALS AND METHODS

Reagents—15(S)-HETE was bought from Cayman Chemicals (Ann Arbor, MI). Growth factor-reduced Matrigel was obtained from BD Biosciences (Bedford, MA). Cells were quiesced by incubating in medium 131 without microvascular growth supplements for 24 h and used to perform the experiments unless otherwise indicated. When the effect of a pharmacological inhibitor was tested on 15(S)-HETE-induced HDMVEC migration, cells were incubated with the inhibitor for 30 min first and added to the upper chamber. When the effect of a pharmacological inhibitor was tested on 15(S)-HETE-induced HDMVEC tube formation, cells were incubated with the inhibitor for 30 min first and plated. A and B, quiescent HDMVECs were treated with and without 0.1 ␮M 15(S)-HETE for the indicated time periods, and either total cellular RNA was isolated and analyzed for MMP-2 and ␤-actin mRNA levels by QRT-PCR (A) or medium was collected and analyzed for MMP-2 activity by gelatin zymography (B). In the case of double immunofluorescence staining, ChIP analysis, EMSA, gelatin zymography, and Western blotting, one representative set of data is shown

RESULTS
Findings
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call